At a House Energy and Commerce Subcommittee on Health hearing today, health care stakeholders urged Congress to consider how to ensure flexibilities remain for patients and health care providers in telehealth beyond the public health emergency.

“It is critical to the health, safety and equitable access of our patients to ensure we can continue to provide telehealth services after the end of the public health emergency,” said Megan Mahoney, M.D., chief of staff at Stanford Health Care, who testified at the hearing.  

In a statement submitted for the hearing, AHA underscored the importance of telehealth in increasing access to care, improving health outcomes and avoiding unnecessary hospitalizations. AHA encouraged Congress to eliminate geographic and originating site restrictions so patients can receive telehealth services in their homes and other locations; cover and reimburse for audio-only services; allow licensed clinicians to provide telehealth services to patients across state lines; ensure adequate reimbursement; and expand the types of health care facilities and providers that can offer telehealth care.

Related News Articles

Headline
The AHA June 14 sent a letter to the Senate Finance Committee, responding to questions included in a white paper the committee wrote on chronic care through…
Headline
The Centers for Disease Control and Prevention June 13 issued a Health Alert Network Health Advisory following a federal health care fraud indictment against…
Headline
The House Energy and Commerce Committee June 12 passed AHA-supported legislation during a markup of bills that passed the Health Subcommittee in May. The…
Headline
The AHA praised House and Senate leaders in letters June 12 for reintroducing the Improving Seniors’ Timely Access to Care Act, bipartisan legislation that…
Headline
The AHA June 7 submitted comments on a discussion draft of the Drug Shortage Prevention and Mitigation Act, bipartisan legislation proposing to provide…
Headline
The House Energy and Commerce Oversight and Investigations subcommittee June 4 hosted a hearing to discuss oversight of the 340B Drug Pricing Program. AHA sent…